The features take much of the friction out of translating raw information into approachable slide decks and infographics. But is that really a good thing?
20hon MSN
SISAQOL-IMI provides guidance for implementing patient-reported outcomes in cancer clinical trials
The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback